CLINICAL-APPLICATION OF NEBULIZED OPIOIDS FOR TREATMENT OF DYSPNEA IN PATIENTS WITH MALIGNANT DISEASE

被引：19

作者：

FARNCOMBE, M

CHATER, S

机构：

[1] Palliative Care Service, Ottawa Civic Hospital, Ottawa, K1Y 4E9, Ontario

来源：

SUPPORTIVE CARE IN CANCER | 1994年 / 2卷 / 03期

关键词：

NEBULIZED OPIOIDS; BREATHLESSNESS; CANCER; TERMINAL DISEASE; ASTHMA;

D O I：

10.1007/BF00417478

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This article describes our experience in the clinical use of nebulized opioids for the management of dyspnoea in patients with terminal cancer by reviewing three specific patient case studies in which this treatment was found to be both safe and effective in controlling breathlessness. The patients were treated with morphine, hydromorphone or anileridine in various doses according to their prior use of opioids. Additional formal studies are being initiated at this Centre.

引用

页码：184 / 187

页数：4

共 17 条

[11]

MASTERS N, 1988, PRACTITIONER, V232, P910

[12]

REGNARD C, 1990, Palliative Medicine, V4, P311, DOI 10.1177/026921639000400410

[13] DYSPNEA IN TERMINALLY ILL CANCER-PATIENTS [J].